Loading...

Nuwellis, Inc.

NUWENASDAQ
HealthcareMedical - Devices
$0.41
$-0.20(-33.06%)

Nuwellis, Inc. (NUWE) Company Profile & Overview

Explore Nuwellis, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Nuwellis, Inc. (NUWE) Company Profile & Overview

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

SectorHealthcare
IndustryMedical - Devices
CEOMr. John L. Erb

Contact Information

952 345 4200
12988 Valley View Road, Eden Prairie, MN, 55344

Company Facts

38 Employees
IPO DateFeb 16, 2012
CountryUS
Actively Trading

Frequently Asked Questions